Clearside Biomedical, Inc. Board of Directors

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Mr. Charles A. Deignan

Mr. Charles A. Deignan

Chief Financial Officer

Mr. Rafael V. Andino

Mr. Rafael V. Andino

Senior Vice President of Engineering & Manufacturing

Mr. Rick McElheny

Mr. Rick McElheny

Senior Vice President of Corporate Development & Alliance Management

Ms. Jenny R. Kobin

Ms. Jenny R. Kobin

Head of Investor Relations

Comments